Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOPS study of filgotinib response biomarkers in ulcerative colitis
NL-OMON53453Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of filgotinib in autoimmune colitis, sponsored by University Medical Center Utrecht. Primary endpoints: Clinical response at 24 weeks and Biomarker identification for response to filgotinib. Started Jun 2023; status: recruiting.
02
Drugs
filgotinib
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on NL-OMON53453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53453.